INFIRMARY LTAC HOSPITAL — History
CCN 012006 | 3-year financial timeline | COVID resilience: 22/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
-8.2%
Revenue CAGR (3yr)
-11.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $12M | $12M | $10M | -15.7% | -8.2% |
| Operating Expenses | $10M | $12M | $12M | +0.4% | +10.1% |
| Operating Margin | 22.1% | 6.0% | -11.9% | -298.6% | +0.0% |
| Net Income | $3M | $1M | $-1M | -267.5% | +0.0% |
| Licensed Beds | 31 | 31 | 31 | +0.0% | +0.0% |
| Total Patient Days | 7,474 | 7,521 | 7,067 | -6.0% | -2.8% |
| Medicare Day % | 47% | 37% | 61% | +63.1% | +13.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 22/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -15.7% ($12M → $10M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-8.2%
This Hospital
+7.6%
State Avg
Latest Margin
-11.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $10M | -28.9% |
| FY2024 (proj) | $9M | -45.9% |
| FY2025 (proj) | $8M | -62.9% |